AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2015
Dec 16, 2015
30786_dirs_2015-12-15_eaa35ea5-b51d-46ef-a29c-c1d74098cc05.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-12-14
Reporting Person: SODERBERG SHAWN MARIE (EVP, General Counsel, Sec)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-12-14 | Bio-Rad A Common Stock | M | 1300 | $122.36 | Acquired | 1952.1164 | Direct |
| 2015-12-14 | Bio-Rad A Common Stock | S | 1300 | $135.50 | Disposed | 652.1164 | Direct |
| 2015-12-14 | Bio-Rad A Common Stock | M | 600 | $119.54 | Acquired | 1252.1164 | Direct |
| 2015-12-14 | Bio-Rad A Common Stock | S | 600 | $135.50 | Disposed | 652.1164 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-12-14 | Non-Qualified Stock Option (right to buy) | $122.36 | M | 1300 | Disposed | 2023-12-02 | Bio-Rad A Common Stock (1300) | Direct |
| 2015-12-14 | Non-Qualified Stock Option (right to buy) | $119.54 | M | 600 | Disposed | 2024-09-10 | Bio-Rad A Common Stock (600) | Direct |
Footnotes
F1: The option became exercisable in five equal annual installments beginning on December 2, 2014, which was the first anniversary of the date on which the option was granted.
F2: The option became exercisable in five equal annual installments beginning on September 10, 2015, which was the first anniversary of the date on which the option was granted.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13